CRBN and Miyoshi myopathy: In MM cells, as the highly effective medicine, Lenalidomide binds DDB1 and Cereblon (CRBN) which generate CRL4CRBN E3 ligase (CRL4) with CUL4 and regulator of Cullins 1.